With pair of trial wins in psoriatic arthritis, Bristol Myers Squibb looks to jump-start stagnant Sotyktu
23rd December 2024 Uncategorised 0Bristol Myers Squibb has reported positive results for two phase 3 trials of Sotyktu in adult patients who have psoriatic arthritis. Without revealing figures, BMS said that the POETYK PsA-1 and POETYK PsA-2 studies achieved their respective primary endpoints, as a significantly greater proportion of patients on Sotyktu achieved at least a 20 percent improvement in symptoms compared to those on placebo at Week 16.
More: With pair of trial wins in psoriatic arthritis, Bristol Myers Squibb looks to jump-start stagnant Sotyktu
Source: fierce